Cre-loxp fate-mapping of Pax6 enhancer active retinal and pancreatic progenitors

Genesis. 2003 Jan;35(1):22-30. doi: 10.1002/gene.10160.

Abstract

Pax6 plays important roles in the control of ocular and pancreatic development. We identified a 450 bp Pax6 enhancer that contains two interacting sequences: a 274 bp fragment sufficient for expression in retinal progenitors and an adjacent 156 bp fragment required for expression in pancreatic progenitors. Since this enhancer is only transiently expressed during embryogenesis, a Cre-loxP fate-mapping strategy was used to investigate the developmental potential of these progenitors. Surprisingly, the labeled retinal precursors predominantly gave rise to horizontal cells, indicating a cell lineage role in horizontal cell differentiation. In the pancreas, all enhancer-specific cells were restricted to endocrine and ductal cell lineages. This result lends support to a model whereby Pax6-expressing progenitors contribute to the adult pancreatic islets and ducts. The progenitor cell-specificity of this enhancer will be useful in studies that require either cell-specific expression or conditional gene inactivation in these cell populations.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Lineage / physiology*
  • Enhancer Elements, Genetic / physiology*
  • Eye Proteins / metabolism
  • Gene Expression Regulation
  • Gene Expression Regulation, Developmental
  • Genes, Reporter
  • Homeodomain Proteins / physiology*
  • Mice
  • Mice, Transgenic
  • PAX6 Transcription Factor
  • Paired Box Transcription Factors
  • Pancreas / cytology*
  • Pancreas / embryology
  • Pancreas / metabolism
  • Repressor Proteins
  • Retina / cytology*
  • Retina / embryology

Substances

  • Eye Proteins
  • Homeodomain Proteins
  • PAX6 Transcription Factor
  • Paired Box Transcription Factors
  • Pax6 protein, mouse
  • Repressor Proteins